New initiative will accelerate the transformation of academic research into high-tech companies and industrial ...

While the Trump administration remains unpredictable, some pharma experts are optimistic that the regulatory landscape will ...

True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...

Solid Power (SLDP) nears commercialization with Samsung SDI and SK On validation, $300M liquidity, and faster timelines—see ...

In thinking about the economics around the launch of pharmaceutical products, it is useful to compare the situation to another area that has seen its economics evolve in recent years: space travel.

Be excited about the future growth opportunity of your company, but also be diligent in planning for that transition, and be wary of the pitfalls that will seek to stop you. The Fast Company Executive ...

The pharmaceutical commercialization landscape is becoming increasingly complex. Tried and true paradigms for capturing market share and securing reimbursement must evolve in the face of demand for ...

Ryan Quigley, CEO of Inizio, discusses how advancement in science are changing the pace of commercialization. Ryan Quigley: The transition has been very smooth. I’ve worked at Inizio for the last four ...

In the weeks following its third quarter 2025 results, Dyadic Applied BioSolutions, Inc. (NASDAQ:DYAI) announced several new partnerships and partnership expansions that build on its foundation of ...